Literature DB >> 19819922

Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.

Dominique Delbeke1, Sigrid Stroobants, Eric de Kerviler, Christian Gisselbrecht, Michel Meignan, Peter S Conti.   

Abstract

Revised guidelines for the staging and response criteria of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) were recently published to include the expanding role of positron emission tomography/computed tomography (PET/CT) using (18)F-fluoro-2-deoxyglucose. Here, we discuss the new guidelines and the need for standardized PET acquisition and interpretation in HL and NHL. We also discuss how the role for CT is evolving in the process of making treatment decisions and provide insight on how best to standardize the use of PET/CT for making therapeutic choices.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19819922     DOI： 10.1634/theoncologist.2009-S2-30

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


  15 in total

1.  The diagnostic value of FDG-PET cannot be judged by iliac bone marrow biopsy.

Authors:  G Cheng
Journal:  Br J Radiol       Date:  2012-08       Impact factor: 3.039

2.  Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma.

Authors:  Antoinette de Jong; Thomas C Kwee; John M H de Klerk; Judit A Adam; Bart de Keizer; Rob Fijnheer; Marie José Kersten; Inge Ludwig; Yvonne W S Jauw; Josée M Zijlstra; Indra C Pieters-Van den Bos; Jaap Stoker; Otto S Hoekstra; Rutger A J Nievelstein
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-04-25

3.  Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer.

Authors:  Irène Buvat; Hatem Necib; Camilo Garcia; Antoine Wagner; Bruno Vanderlinden; Patrick Emonts; Alain Hendlisz; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-19       Impact factor: 9.236

4.  Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.

Authors:  Hugo J A Adams; Thomas C Kwee; Malou A Vermoolen; Bart de Keizer; John M H de Klerk; Judit A Adam; Rob Fijnheer; Marie José Kersten; Jaap Stoker; Rutger A J Nievelstein
Journal:  Eur Radiol       Date:  2013-04-17       Impact factor: 5.315

5.  Current status of PET/CT in the diagnosis and follow up of lymphomas.

Authors:  Carlos Alberto Buchpiguel
Journal:  Rev Bras Hematol Hemoter       Date:  2011

6.  Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?

Authors:  Shonit Punwani; Stuart A Taylor; Ziauddin Z Saad; Alan Bainbridge; Ashley Groves; Stephen Daw; Ananth Shankar; Steve Halligan; Paul D Humphries
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-30       Impact factor: 9.236

7.  Correlation of tissue biopsy and fine needle aspiration cytology with positron emission tomography results.

Authors:  Daniel Rosen; Bruce Herrington; Peeyush Bhargava; Rodolfo Laucirica; Gordana Verstovsek
Journal:  Patholog Res Int       Date:  2011-04-06

8.  Manifestation of lymphoma expansion following lymphatic drainage on 18F-FDG PET/CT.

Authors:  Silvia A Eshuis; Rudi A J O Dierckx; Paul J H van Snick; Riemer H J A Slart; Andor W J M Glaudemans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-07       Impact factor: 9.236

9.  Usefulness of the computed tomography and magnetic resonance in evaluation of progress of treatment of the neoplasmatic diseases in children.

Authors:  Jolanta Myga-Porosiło; Hanna Borowiak; Wojciech Sraga; Zuzanna Jackowska; Magdalena Serafin; Ewa Kluczewska
Journal:  Pol J Radiol       Date:  2012-07

10.  New axillary lymph nodal F-18 fluoro-deoxy glucose uptake in an interim positron emission tomography scan - not always a sign of disease progression.

Authors:  Kuruva Manohar; Kanhaiyalal Agrawal; Anish Bhattacharya; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.